BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 20979709)

  • 1. Severe neuroleptic malignant syndrome: successful treatment with high-dose lorazepam and diazepam: a case report.
    Tsai MC; Huang TL
    Chang Gung Med J; 2010; 33(5):576-80. PubMed ID: 20979709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroleptic malignant syndrome: further lessons from a case report.
    Casamassima F; Lattanzi L; Perlis RH; Litta A; Fui E; Bonuccelli U; Fricchione G; Cassano GB
    Psychosomatics; 2010; 51(4):349-54. PubMed ID: 20587766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapy of neuroleptic malignant syndrome.
    Lazarus A
    Psychiatr Dev; 1986; 4(1):19-30. PubMed ID: 3703852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zuclopenthixol-induced neuroleptic malignant syndrome in an adolescent girl.
    Erermis S; Bildik T; Tamar M; Gockay A; Karasoy H; Ercan ES
    Clin Toxicol (Phila); 2007; 45(3):277-80. PubMed ID: 17453880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diazepam-responsive malignant catatonia in a patient with an initial clinical diagnosis of neuroleptic malignant syndrome: a case report].
    Mishima T; Tsuboi Y; Higuchi MA; Tsugawa J; Obata T; Yamada T
    Brain Nerve; 2011 May; 63(5):503-7. PubMed ID: 21515931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and treatment of neuroleptic malignant syndrome.
    Guerrero RM; Shifrar KA
    Clin Pharm; 1988 Sep; 7(9):697-701. PubMed ID: 3240662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ziprasidone- and lithium-induced neuroleptic malignant syndrome.
    Borovicka MC; Bond LC; Gaughan KM
    Ann Pharmacother; 2006 Jan; 40(1):139-42. PubMed ID: 16352776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Case report: Neuroleptic malignant syndrome and diagnostic difficulties].
    Khouri C; Planès S; Logerot S; Villier C; Mallaret M
    Encephale; 2016 Jun; 42(3):277-80. PubMed ID: 26923996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroleptic malignant syndrome secondary to quetiapine.
    Gortney JS; Fagan A; Kissack JC
    Ann Pharmacother; 2009 Apr; 43(4):785-91. PubMed ID: 19299325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The neuroleptic malignant syndrome in an adolescent. Its treatment with dantrolene, bromocryptin and diazepam].
    Real Rodríguez B; Ruibal JL; Grande Rodríguez S; Sueiro Pita B
    An Esp Pediatr; 1996 Jan; 44(1):60-2. PubMed ID: 8849063
    [No Abstract]   [Full Text] [Related]  

  • 11. Response to benzodiazepines and the clinical course in malignant catatonia associated with schizophrenia: A case report.
    Ohi K; Kuwata A; Shimada T; Yasuyama T; Nitta Y; Uehara T; Kawasaki Y
    Medicine (Baltimore); 2017 Apr; 96(16):e6566. PubMed ID: 28422845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroleptic malignant syndrome: a review and report of six cases.
    Kasantikul D; Kanchanatawan B
    J Med Assoc Thai; 2006 Dec; 89(12):2155-60. PubMed ID: 17214072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroleptic malignant syndrome due to olanzapine.
    Hall KL; Taylor WH; Ware MR
    Psychopharmacol Bull; 2001; 35(3):49-54. PubMed ID: 12397878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neuroleptic malignant syndrome: a life-threatening complication that can be treated effectively].
    van Waarde JA; Muller ME; Verweg B
    Ned Tijdschr Geneeskd; 2006 Nov; 150(46):2517-20. PubMed ID: 17152323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroleptic malignant syndrome versus serotonin syndrome: the search for a diagnostic tool.
    Sokoro AA; Zivot J; Ariano RE
    Ann Pharmacother; 2011 Sep; 45(9):e50. PubMed ID: 21878660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Catatonia in a 14 year-old girl: treatment with clorazepam and carbamazepine, a 10-year follow-up].
    Askenazy F; Dor E; Benoit M; Dupuis G; Serret S; Myquel M; Seddiki Y
    Encephale; 2010 Feb; 36(1):46-53. PubMed ID: 20159196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A study of neuroleptic malignant syndrome in the presenium and senium].
    Suzuki I; Honma H; Watanabe N; Matsubara S; Koyama T
    Seishin Shinkeigaku Zasshi; 1998; 100(6):387-97. PubMed ID: 9745353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroleptic malignant syndrome associated with the use of prochlorperazine in a patient with a recent history of antipsychotic-induced neuroleptic malignant syndrome.
    Musselman ME; Browning LA; Parker D; Saely S
    Ann Pharmacother; 2011 Nov; 45(11):e61. PubMed ID: 21972252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroleptic malignant syndrome: a case report.
    Fekadu A; Wakwoya A
    Ethiop Med J; 1999 Jul; 37(3):195-8. PubMed ID: 11957317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroleptic malignant syndrome: a concealed diagnosis with multitreatment approach.
    Velosa A; Neves A; Barahona-Corrêa JB; Oliveira-Maia AJ
    BMJ Case Rep; 2019 Jun; 12(6):. PubMed ID: 31213433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.